Trastuzumab Unknown Status Phase 2 Trials for Metastatic Breast Cancer / Hepatic Metastases Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00250874Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer
NCT00842998Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer
NCT01387373Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer
NCT01387295Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease